| Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation H Qin, WI Yeh, P De Sarno, AT Holdbrooks, Y Liu, MT Muldowney, ... Proceedings of the National Academy of Sciences 109 (13), 5004-5009, 2012 | 260 | 2012 |
| Divergent phenotypes of human regulatory T cells expressing the receptors TIGIT and CD226 CA Fuhrman, WI Yeh, HR Seay, P Saikumar Lakshmi, G Chopra, L Zhang, ... The Journal of Immunology 195 (1), 145-155, 2015 | 233 | 2015 |
| Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers KW Chang, TC Lee, WI Yeh, MY Chung, CJ Liu, LY Chi, SC Lin British journal of cancer 91 (8), 1551-1555, 2004 | 122 | 2004 |
| Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers SC Lin, CJ Liu, WI Yeh, MT Lui, KW Chang, CS Chang Cancer letters 243 (1), 47-54, 2006 | 106 | 2006 |
| Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells E Beurel, WI Yeh, SM Michalek, LE Harrington, RS Jope The Journal of Immunology 186 (3), 1391-1398, 2011 | 101 | 2011 |
| Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3 E Beurel, O Kaidanovich-Beilin, WI Yeh, L Song, V Palomo, SM Michalek, ... The Journal of Immunology 190 (10), 5000-5011, 2013 | 97 | 2013 |
| Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing De Novo Autoreactive T-Cell Receptors in Type 1 Diabetes WI Yeh, HR Seay, B Newby, AL Posgai, FB Moniz, A Michels, ... Frontiers in Immunology 8, 1313, 2017 | 91 | 2017 |
| Heme Oxygenase-1 Gene Promoter Polymorphism is Associated with Risk of Gastric Adenocarcinoma and Lymphovascular Tumor Invasion SS Lo, SC Lin, CW Wu, JH Chen, WI Yeh, MY Chung, WY Lui Annals of surgical oncology 14, 2250-2256, 2007 | 73 | 2007 |
| Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells K Kehn, R Berro, A Alhaj, ME Bottazzi, WI Yeh, Z Klase, R Van Duyne, ... Oncogene 26 (35), 5060-5069, 2007 | 56 | 2007 |
| IFNγ inhibits Th17 differentiation and function via Tbet-dependent and Tbet-independent mechanisms WI Yeh, IL McWilliams, LE Harrington Journal of neuroimmunology 267 (1-2), 20-27, 2014 | 55 | 2014 |
| Innate inflammation drives NK cell activation to impair Treg activity JW Dean, LD Peters, CA Fuhrman, HR Seay, AL Posgai, SE Stimpson, ... Journal of autoimmunity 108, 102417, 2020 | 43 | 2020 |
| Autoreactive Tbet-positive CD4 T cells develop independent of classic Th1 cytokine signaling during experimental autoimmune encephalomyelitis WI Yeh, IL McWilliams, LE Harrington The Journal of Immunology 187 (10), 4998-5006, 2011 | 38 | 2011 |
| Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways E Agbottah, WI Yeh, R Berro, Z Klase, C Pedati, K Kehn-Hall, W Wu, ... AIDS Research and Therapy 5, 1-16, 2008 | 26 | 2008 |
| CD226 deletion reduces type 1 diabetes in the NOD mouse by impairing thymocyte development and peripheral T cell activation MR Shapiro, WI Yeh, JR Longfield, J Gallagher, CM Infante, S Wellford, ... Frontiers in immunology 11, 2180, 2020 | 23 | 2020 |
| Lupus susceptibility gene Esrrg modulates regulatory T cells through mitochondrial metabolism W Li, M Gong, YP Park, AS Elshikha, SC Choi, J Brown, N Kanda, WI Yeh, ... JCI insight 6 (14), 2021 | 13 | 2021 |
| Clinical applications of regulatory T cells in adoptive cell therapies GP Marshall, J Cserny, DJ Perry, WI Yeh, HR Seay, AG Elsayed, ... Cell & gene therapy insights 4 (1), 405, 2018 | 9 | 2018 |
| Fox 3rd H Qin, WI Yeh, P De Sarno, AT Holdbrooks, Y Liu, MT Muldowney, ... TH, Park, K., Harrington, LE, Raman, C., Benveniste, EN, 5004-5009, 2012 | 7 | 2012 |
| Regulation of effector CD4+ T cell functions by Tbet (48.13) WI Yeh, LE Harrington The Journal of Immunology 182 (1_Supplement), 48.13-48.13, 2009 | 5 | 2009 |
| Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability P Thirawatananond, ME Brown, LK Sachs, JM Arnoletti, WI Yeh, ... Diabetes 72 (11), 1629-1640, 2023 | 2 | 2023 |
| Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8+ T cells LD Peters, WI Yeh, JM Arnoletti, ME Brown, AL Posgai, CE Mathews, ... Frontiers in Immunology 14, 1142648, 2023 | 2 | 2023 |
